探索脆弱和执行功能障碍之间的关系:前额白质超强度的作用
Natalia Pozo1, César Romero2, Maricarmen Andrade3
1Department of Neurology, Hospital San Borja Arriarán, Santiago, Chile.
Frontiers in aging neuroscience
|September 15, 2023
概括
额头白质过强度部分介于老年人脆弱和执行功能障碍之间的联系. 这表明其他大脑变化也会导致脆弱个体的认知衰退.
科学领域:
- 老年医学 老年医学
- 神经科学是一个神经科学.
- 放射学 放射学是一门学科.
背景情况:
- 虚弱是一种与执行功能障碍和白质超强度 (WMH) 相关的老年综合征.
- 在脆弱个体中,执行功能障碍与大脑变化之间的确切关系尚不清楚.
- 假设前额WMH能够调解脆弱性和执行功能障碍之间的关联.
研究的目的:
- 调查前额白质高强度 (F-WMH) 在没有痴呆症的老年人中脆弱性和执行功能障碍之间的关系中的调解作用.
主要方法:
- 113名65岁以上的非痴呆症患者接受了神经心理测试,临床面试,体检和3次特斯拉大脑MRI.
- 使用脆弱性表型得分 (0-5) 评估脆弱性.
- 额头WMH (F-WMH) 使用与年龄相关的白质变化得分来量化;进行中介分析.
主要成果:
- 较高的脆弱性得分与更多的抑郁症状和较差的执行功能相关.
- 回归分析显示,脆弱性得分 (β = -0.201) 和F-WMH (β = -0.152) 对执行功能有显著的直接影响.
- F-WMH显示了脆弱性和执行功能之间的小部分调解效应 (β = -0.0395).
结论:
- 额头白质过强度在虚弱和执行功能障碍之间的关联中起到较小的调解作用.
- 其他神经病理和神经功能因素可能会导致脆弱的老年人执行功能障碍.
相关概念视频
01:30Attention-Deficit/Hyperactivity Disorder
90
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
90
01:14Role of Cerebellum and Prefrontal Cortex in Memory
470
The cerebellum, while traditionally associated with motor control, also plays a crucial role in memory, particularly in procedural memory, which involves learning motor tasks that become automatic through repetition. For example, studies have shown that when the cerebellum is damaged, individuals or animals lose the ability to learn conditioned motor responses, such as the conditioned eye-blink response in classical conditioning experiments with rabbits. This study demonstrates the...
470
01:26Alzheimer's Disease: Overview
517
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
517